CRNXCrinetics Pharmaceuticals, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $37.23 (+0.00% today)

Market Cap: $3.90B

P/E (TTM): -7.50

Analyst Upside: 127.4%

Relative Strength (RS%): 1

-35.8% from 52-week high

Back to Scanner

CRNX

NASDAQRS 1Score 15

Crinetics Pharmaceuticals, Inc.

HealthcareBiotechnology$3.90B1 setup passing
$37.23
0.0% ($0.00)
-35.8% from 52W High
P/E (TTM)
-7.50
Fwd P/E
PEG
Analyst Upside
+127.4%
EPS Growth
Gross Margin
108.5%
ROE
-41.5%
D/E
0.05
Div Yield
0.0%
Avg Volume
1.2M

Price Chart

Key Levels

SMA 200
$39.80
SMA 50
$42.55
Price
$37.23
52W High
$57.99
Target
$84.67

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst